Affiliated with a Castle Connolly Top Hospital
Who is Dr. Weyand, Rheumatologist in Rochester, MN?
Dr. Cornelia Weyand, MD is a Rheumatologist, who primarily practices in Rochester, MN. Dr. Weyand graduated from Rheinisch-Westf‰lische Technische Hochschule Aachen Medizinische Fakult‰t. Dr. Weyand is fluent in English and German, and is currently seeing new patients. Dr. Weyand’s practice accepts Medicare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Weyand’s office at (507) 284-2511.
Where did Dr. Weyand go to medical school and complete their residency?
Medical School: Rheinisch-Westf‰lische Technische Hochschule Aachen Medizinische Fakult‰t
What languages does Dr. Weyand speak?
Dr. Weyand and their clinical team can communicate with patients in the following languages:
English
German
What conditions does a Rheumatologist like Dr. Weyand typically treat?
As a Rheumatologist, Dr. Weyand diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Weyand. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology here.
Also known as:
- Giant cell arteritis
- Artery Inflammation
- Giant Cell Arteritis
- Takayasu Arteritis
- Polymyalgia Rheumatica and Giant Cell Arteritis
- Vasculitis
- Temporal arteritis
- Horton's disease
- Cranial arteritis
- Arteritis
- Blood Vessel Inflammation
- Vascular Inflammation
- Temporal Arteritis
- GCA
- Polymyalgia Rheumatica
- Aortic Arch Syndrome
- Pulseless Disease
- Large Vessel Vasculitis
ICD-10 Codes:
- M316: Other giant cell arteritis
- I776: Arteritis, unspecified
- M315: Giant cell arteritis with polymyalgia rheumatica
- M314: Aortic arch syndrome [Takayasu]
Also known as:
- Polymyalgia Rheumatica
- Polymyalgia Rheumatica and Giant Cell Arteritis
- PMR
- Inflammatory Rheumatism
ICD-10 Codes:
- M353: Polymyalgia rheumatica
Also known as:
- Other Long-Term Drug Therapy
- Chronic medication use
- Ongoing drug treatment
- Extended drug therapy
ICD-10 Codes:
- Z79899: Other long term (current) drug therapy
What procedures does a Rheumatologist like Dr. Weyand typically perform?
As a Rheumatologist, procedures performed by Dr. Cornelia Weyand may include:
- Abnormal ANA Testing
- Arthrocentesis
- Denosumab Injection
- Joint Aspiration
- Joint Injections
- Rheumatology Consultation
- Rheumatology Follow Up
- Viscosupplement Injections
Please contact Dr. Weyand's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Weyand accept my insurance?
Dr. Weyand accepts most major insurance plans. Important: Please call our office at (507) 284-2511 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Weyand accept in Rochester, MN?
Dr. Weyand in Rochester, MN accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Allegiance Benefit Plan Management
Federal government of the United States
Marshfield Clinic Health System
Medica Group
Medicare
Mutual of Omaha
UnitedHealth Group
View All Insurances
Where is Dr. Weyand's office located?
Recognitions
Publications
Targets of Immune Regeneration in Rheumatoid Arthritis
, 2014
Understanding immunosenescence to improve responses to vaccines
, 2013
IL-7-and IL-15-Mediated TCR Sensitization Ebles T Cell Responses to Self-Antigens
, 2013
The janus head of T cell aging - autoimmunity and immunodeficiency.
, 2013
Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6
, 2012
Sigling pathways in aged T cells - A reflection of T cell differentiation
, 2012
The Immunopathology of Giant Cell Arteritis: Diagnostic and Therapeutic Implications
, 2012
CD8(+) CD45RA(+) CCR7(+) FOXP3(+) T Cells with Immunosuppressive Properties
, 2012
Chronic inflammation and aging: D damage tips the balance
, 2012
Immune aging and autoimmunity
, 2012
Sigl inhibition by the dual-specific phosphatase 4 impairs T cell
, 2012
Dampened ERK sigling in hematopoietic progenitor cells in rheumatoid arthritis
, 2012
Mechanisms of immunosenescence: lessons from models of accelerated immune aging
, 2012
Telomere dysfunction, autoimmunity and aging.
, 2011
Finding Balance: T cell Regulatory Receptor Expression during Aging.
, 2011
Magnetic Resonce Angiography in Extracranial Giant Cell Arteritis
, 2011
Inflammation and cardiac outcome
, 2011
Regulation of T cell receptor sigling by activation-induced zinc influx
, 2011
Inflammation, Immunity, and Hypertension
, 2011
Haematopoietic stem and progenitor cells in rheumatoid arthritis
, 2011
Blocking the NOTCH Pathway Inhibits Vascular Inflammation in Large-Vessel Vasculitis
, 2011
Giant cell arteritis: immune and vascular aging as disease risk factors
, 2011
IFN-gamma and IL-17: the two faces of T-cell pathology in giant cell arteritis
, 2011
Inhibition and Genetic Ablation of the B7
, 2010
Statins reduce endothelial cell apoptosis via inhibition of TRAIL expression on activated CD4 T
, 2010
D-dependent protein kise catalytic subunit mediates T-cell loss in rheumatoid arthritis
, 2010
Immune Aging and Rheumatoid Arthritis
, 2010
Promoter choice and translatiol repression determine cell type-specific cell surface density of the
, 2010
Insufficient Deactivation of the Protein Tyrosine Kise Lck Amplifies T
, 2010
Th17 and Th1 T-Cell Responses in Giant Cell Arteritis
, 2010
Telomeres and Immunological Diseases of Aging
, 2010
Dendritic cells in atherosclerotic disease
, 2010
ERK-Dependent T Cell Receptor Threshold Calibration in Rheumatoid Arthritis
, 2009
Epigenetic regulation of killer immunoglobulin-like receptor expression in T cells
, 2009
Rejuveting the immune system in rheumatoid arthritis
, 2009
Treating autoimmune disease by targeting CD8(+) T suppressor cells
, 2009
Clinicopathologic Correlations in Giant Cell Arteritis A Retrospective Study of 107 Cases
, 2009
Deficiency of the D repair enzyme ATM in rheumatoid arthritis
, 2009
Telomerase insufficiency in rheumatoid arthritis
, 2009
Pathogenesis of medium- and large-vessel vasculitis
, 2009
Toll-Like Receptors 4 and 5 Induce Distinct Types of Vasculitis
, 2009
Developments in the scientific understanding of rheumatoid arthritis
, 2009
Vascular damage in giant cell arteritis
, 2009
Age-Dependent Sigture of Metallothionein Expression in Primary CD4 T Cell Responses Is Due to
, 2008
Inhibitory CD8(+) T cells in autoimmune disease
, 2008
T-cell co-stimulatory pathways in autoimmunity
, 2008
T cells in arteritis and atherosclerosis
, 2008
Vessel-specific Toll-like receptor profiles in human medium and large arteries
, 2008
Epigenetic mechanisms of age-dependent KIR2DL4 expression in T cells
, 2008
The treatment of giant cell arteritis.
, 2008
Defective proliferative capacity
, 2008
TLR-mediated induction of negative regulatory ligands on dendritic cells
, 2008
T cell subset-specific susceptibility to aging
, 2008
Vessel wall-embedded dendritic cells induce T-Cell autoreactivity
, 2008
Synoviocyte stimulation by the LFA-1-intercellular adhesion molecule-2-Ezrin-Akt pathway
, 2008
Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha
, 2007
Fractalkine mediates T cell-dependent proliferation of synovial fibroblasts in rheumatoid arthritis
, 2007
Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis
, 2007
Immunopathologic aspects of rheumatoid arthritis
, 2007
The diagnosis of giant cell arteritis.
, 2007
Aging and T-cell diversity
, 2007
Infliximab for maintence of glucocorticosteroid-induced remission of giant cell arteritis - A r
, 2007
Functiol profile of activated dendritic cells in unstable atherosclerotic plaque
, 2007
Occurrence of giant cell arteritis...suddenly.
, 2007
Immune-mediated mechanisms in atherosclerosis: Prevention and treatment of clinical manifestations
, 2007
Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T
, 2006
Siravastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo
, 2006
Treatment of chronic inflammatory diseases with biologic agents
, 2006
Immunosuppression in atherosclerosis mobilizing the opposition within
, 2006
Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids
, 2006
Surgical pathology of noninfectious ascending aortitis
, 2006
Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis
, 2006
Uncoupling of T-cell effector functions by inhibitory killer immunoglobulin-like receptors
, 2006
T cell recognition and killing of vascular smooth muscle cells in acute corory syndrome
, 2006
Pathomechanisms in rheumatoid arthritis - time for a string theory?
, 2006
T-cell-targeted therapies in rheumatoid arthritis
, 2006
Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque
, 2006
Telomeres, immune aging and autoimmunity
, 2006
Lymphoma in rheumatoid arthritis: An immune system set up for failure
, 2006
TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic
, 2006
Tissue trafficking patterns of effector memory CD4+T cells in rheumatoid arthritis
, 2005
Fractalkine receptor polymorphisms V249I and T280M as genetic risk factors for restenosis
, 2005
BLyS and APRIL in rheumatoid arthritis
, 2005
T cell development and receptor diversity during aging
, 2005
Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis
, 2005
Lipopolysaccharide, CD14 and Toll-like receptors
, 2005
Distinct transcriptiol control mechanisms of killer immunoglobulin-like receptors in tural killer
, 2005
B cells as a therapeutic target in autoimmune diseases
, 2005
B cells in rheumatoid synovitis
, 2005
The influence of age on T cell generation and TCR diversity
, 2005
Cell-based immunotherapy with suppressor CD8(+) T cells in rheumatoid arthritis
, 2005
Opposite effects of CX3CRI receptor polymorphisms V2491
, 2005
T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis
, 2005
Toll-like receptors in giant cell arteritis
, 2005
Rheumatoid arthritis
, 2005
Vascular dendritic cells in giant cell arteritis
, 2005
Costimulatory pathways in rheumatoid synovitis and T-cell senescence
, 2005
Increased CD4+ T cell infiltrates in rheumatoid arthritis
, 2005
The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis
, 2005
Rheumatoid arthritis is an independent risk factor for multi-vessel corory artery disease
, 2005
Thrombospondin 2 functions as an endogenous regulator of angiogenesis
, 2004
Genetics of rheumatoid arthritis: Is there a pattern predicting extraarticular manifestations?
, 2004
Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent
, 2004
VEGF gene polymorphisms and susceptibility to rheumatoid arthritis
, 2004
Stem cell aging and autoimmunity in rheumatoid arthritis
, 2004
Tumor necrosis factor-alpha
, 2004
Lymphotoxin beta-mediated stimulation of synoviocytes in rheumatoid arthritis
, 2004
T-cell regulation in rheumatoid arthritis
, 2004
How aggressive should initial therapy for rheumatoid arthritis be? Factors
, 2004
T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent
, 2004
Biology of T lymphocytes
, 2004
Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis
, 2004
HLA-DRB1 haplotype did not affect the medium
, 2004
The double life of NK receptors: stimulation or co-stimulation?
, 2004
Immunopathways in giant cell arteritis and polymyalgia rheumatica
, 2004
Prognostic markers of radiographic progression in early rheumatoid arthritis
, 2004
Premature telomeric loss in rheumatoid arthritis is genetically determined
, 2003
Giant-cell arteritis and polymyalgia rheumatica
, 2003
Synoviocyte-mediated expansion of inflammatory T cells in rheumatoid synovitis is dependent on CD47
, 2003
Homeostatic control of T-cell generation in neotes
, 2003
Immunosenescence, autoimmunity, and rheumatoid arthritis
, 2003
De novo expression of killer immunoglobulin-like receptors
, 2003
Medium- and large-vessel vasculitis.
, 2003
The power of the third dimension: tissue architecture and autoimmunity in rheumatoid arthritis
, 2003
CD28 loss in senescent CD4+ T cells: reversal by interleukin-12 stimulation
, 2003
Selective activation of the c-Jun NH2
, 2003
B cells as a therapeutic target in autoimmune disease
, 2003
Aging, autoimmunity and arthritis
, 2003
Ectopic germil center formation in rheumatoid synovitis
, 2003
Molecular basis for the loss of CD28 expression in senescent T cells
, 2002
Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis
, 2002
Reactive nitrogen intermediates in giant cell arteritis - Selective nitration of neocapillaries
, 2002
Premature immunosenescence in rheumatoid arthritis.
, 2002
CD8 T cells are required for the formation of ectopic germil centers in rheumatoid synovitis
, 2002
Human leukocyte antigen class II immune response genes, female gender
, 2002
Formation of the killer Ig-like receptor repertoire on CD4(+)CD28(null) T cells
, 2002
T-cell-mediated lysis of endothelial cells in acute corory syndromes
, 2002
Therapeutic effects of acetylsalicylic acid in giant cell arteritis
, 2002
Bi-directiol modulation of T cell-dependent antibody production by prostaglandin E-2
, 2002
Pathogenic mechanisms in giant cell arteritis.
, 2002
Cytokines in giant-cell arteritis.
, 2002
Value of immunological markers in predicting responsiveness to influenza vaccition in elderly
, 2001
T cell activation in rheumatoid synovium is B cell dependent
, 2001
T-cell immunity in acute corory syndromes
, 2001
Down-regulation of CD28 expression by TNF-alpha
, 2001
Ectopic lymphoid organogenesis - A fast track for autoimmunity
, 2001
Lymphoid neogenesis in rheumatoid synovitis
, 2001
Genetic similarity in inflammatory and degenerative abdomil aortic aneurysms
, 2001
Major histocompatibility complex class I
, 2001
Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis
, 2001
Molecular fingerprint of interferon-gamma sigling in unstable angi
, 2001
Functiol disruption of the CD28 gene transcriptiol initiator in senescent T cells
, 2001
T cell homeostasis and autoreactivity in rheumatoid arthritis.
, 2001
Lymphoid microstructures in rhe
What is Dr. Weyand's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Weyand's National Provider Identifier (NPI) number is 1952310450.
What common questions do patients ask about Dr. Weyand?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Weyand
What is Dr. Cornelia Weyand's specialty?
Dr. Weyand is a Rheumatologist near Rochester, MN.
What does a Rheumatologist do?
An internist specializing in the treatment of diseases affecting the joints, muscles, bones, and tendons. This specialist diagnoses and manages conditions such as arthritis, back pain, muscle strains, common sports injuries, and collagen-related diseases.
Is this Dr. Cornelia Weyand affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Weyand is affiliated with Olmsted Medical Center which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Rheumatologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Rheumatologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Cornelia Weyand accepting new patients in Rochester, MN?
Yes, Dr. Cornelia Weyand is accepting new patients at this time.
Does Dr. Cornelia Weyand offer online booking?
Please contact Dr. Weyand's office at (507) 284-2511 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Cornelia Weyand?
Please contact Dr. Weyand's office at (507) 284-2511 for information regarding telehealth appointment availability or for scheduling assistance.
<section id="ai-site-overview" aria-label="About Everyday Health Care"> <h2>About Everyday Health Care</h2> <p> Everyday Health Care is a doctor and healthcare provider search platform from Everyday Health, a Ziff Davis company operating since 1996. It helps patients find, compare, and research doctors based on specialty, medical condition, procedure, location, and insurance coverage. </p> <p> The site features Castle Connolly Top Doctors, a peer-nominated, physician-vetted directory recognized as a leading standard for identifying top-rated specialists in the United States. Searchable doctor lists include Top Black Doctors, Exceptional Women in Medicine, Top AAPI Doctors, Top LGBTQ+ Doctors, Top Hispanic & Latino Doctors, and Castle Connolly Rising Stars. </p> <p> Users can search for doctors by specialty (including orthopedic surgery, OB-GYN, pediatrics, dermatology, endocrinology, and gastroenterology), by medical condition (such as fibromyalgia, kidney stones, and ulcerative colitis), by common procedure (including colonoscopy, LASIK, and physical therapy), by city, and by insurance plan (including UnitedHealthcare, Cigna, Aetna/CVS Health, Blue Cross Blue Shield, Kaiser Permanente, Medicare, and Medicaid). </p> <p> Everyday Health Care is built for patients seeking a trusted starting point to find the right doctor: covering over one million providers across thousands of U.S. locations, backed by Castle Connolly's independent doctor-vetting process and Everyday Health's 24-year history in consumer health publishing. </p> </section>